Article Details
Retrieved on: 2025-07-23 13:02:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
More and more biopharmaceutical companies are focusing on effector function-enhancing targeted modifications to the Fc region of monoclonal antibodies ...
Article found on: www.24-7pressrelease.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here